Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Aceragen, Inc (ACGN)  
$0.38 0.00 (0.00%) as of 4:30 Mon 8/21


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 8,423,000
Market Cap: 3.20(M)
Last Volume: 1,933,173 Avg Vol: 663,431
52 Week Range: $0.38 - $1.85
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    AMEX COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Idera Pharmaceuticals is a biopharmaceutical company focused on the clinical development, and the commercialization, of drug candidates for rare disease indications characterized by patient populations with unmet medical needs. Co.'s focus is to identify and acquire rights to development and commercial stage rare disease programs through new business development opportunities, including additional alternatives. Co. is evaluating intratumoral tilsotolimod in combination with nivolumab, an anti-Progressive Disease 1 antibody marketed as Opdivo® by Bristol Myers Squibb Company, and ipilimumab for the treatment of multiple solid tumors in a multicohort trial.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 26,965 26,965
Total Buy Value $0 $0 $38,290 $38,290
Total People Bought 0 0 1 1
Total Buy Transactions 0 0 1 1
Total Shares Sold 0 0 226,310 273,476
Total Sell Value $0 $0 $333,274 $420,198
Total People Sold 0 0 4 4
Total Sell Transactions 0 0 8 9
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 234
  Page 3 of 10  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Milano Vincent President & CEO   •       •      –    2021-01-05 4 S $3.91 $10,700 D/D (2,740) 211,821 74%     
   Kirby John J. Chief Financial Officer   •       –      –    2021-01-05 4 S $3.90 $3,362 D/D (862) 35,575 74%     
   Geraghty James A Director   –       •      –    2021-01-04 4 A $4.02 $19,501 D/D 4,851 104,770     -
   Goldberg Mark Alan Director   –       •      –    2021-01-04 4 A $4.02 $13,877 D/D 3,452 38,099     -
   Dougherty Michael R Director   –       •      –    2021-01-04 4 A $4.02 $14,130 D/D 3,515 37,645     -
   Schafer Carol Director   –       •      –    2021-01-04 4 A $4.02 $14,552 D/D 3,620 48,488     -
   Soland Daniel B Chief Operating OfficerOfficer   •       –      –    2021-01-04 3 IO $0.00 $0 D/D 0 18,843 -75%     
   Milano Vincent President & CEO   •       •      –    2020-12-22 4 AS $4.32 $160,525 D/D (37,169) 214,561 -73%     
   Milano Vincent President & CEO   •       •      –    2020-12-18 4 A $0.00 $0 D/D 128,170 251,730     -
   Zein Youssef El 10% Owner   –       –       •   2020-12-11 4 B $1.82 $127,293 I/I 69,941 5,497,638 1.5 -75%     
   Schafer Carol Director   –       •      –    2020-10-01 4 A $2.25 $13,750 D/D 6,111 44,868     -
   Geraghty James A Director   –       •      –    2020-10-01 4 A $2.25 $19,499 D/D 8,666 99,919     -
   Pien Howard H Director   –       •      –    2020-10-01 4 A $2.25 $12,562 D/D 5,583 45,457     -
   Dougherty Michael R Director   –       •      –    2020-10-01 4 A $2.25 $12,875 D/D 5,722 34,130     -
   Goldberg Mark Alan Director   –       •      –    2020-10-01 4 A $2.25 $13,874 D/D 6,166 34,647     -
   Zein Youssef El 10% Owner   –       –       •   2020-07-13 4 B $1.72 $1,289,988 I/I 749,993 5,427,697 1.5 146%     
   Goldberg Mark Alan Director   –       •      –    2020-07-01 4 A $1.79 $13,874 D/D 7,751 28,481     -
   Pien Howard H Director   –       •      –    2020-07-01 4 A $1.79 $12,562 D/D 7,018 39,874     -
   Geraghty James A Director   –       •      –    2020-07-01 4 A $1.79 $19,500 D/D 10,894 91,253     -
   Dougherty Michael R Director   –       •      –    2020-07-01 4 A $1.79 $12,875 D/D 7,193 28,408     -
   Schafer Carol Director   –       •      –    2020-07-01 4 A $1.79 $13,749 D/D 7,681 38,757     -
   Zein Youssef El 10% Owner   –       –       •   2020-04-17 4 D $0.00 $0 I/I (150,195) 1,288,368     -
   Zein Youssef El 10% Owner   –       –       •   2020-04-07 4 B $1.52 $4,620,061 I/I 3,039,514 6,260,832 1.5 60%     
   Dougherty Michael R Director   –       •      –    2020-04-01 4 A $1.28 $12,876 D/D 10,059 21,215     -
   Geraghty James A Director   –       •      –    2020-04-01 4 A $1.28 $19,105 D/D 14,926 80,359     -
  234 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 3 of 10
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us